P

Inventor

RAFIQUE ASHIQUE

US19 patents
⚠️ This page may combine multiple inventors who share the name “RAFIQUE ASHIQUE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

REGENERON PHARMA

13 patents
US8043617B2Oct 25, 2011

Human antibodies to human IL-6 receptor

REGENERON PHARMA91 citations99
US7582298B2Sep 1, 2009

High affinity antibodies to human IL-6 receptor

REGENERON PHARMA390 citations99
US7605237B2Oct 20, 2009

High affinity human antibodies to human IL-4 receptor

REGENERON PHARMA194 citations98
US7794717B2Sep 14, 2010

High affinity human antibodies to human IL-4 receptor

REGENERON PHARMA34 citations95
US10179819B2Jan 15, 2019

Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof

REGENERON PHARMA25 citations93
US9884916B2Feb 6, 2018

High affinity antibodies to human IL-6 receptor

REGENERON PHARMA13 citations92
US11155633B2Oct 26, 2021

Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof

REGENERON PHARMA9 citations85
US9308256B2Apr 12, 2016

Method of treating rheumatoid arthritis with an anti-IL-6R antibody

REGENERON PHARMA11 citations84
US11370843B2Jun 28, 2022

High affinity antibodies to human IL-6 receptor

REGENERON PHARMA1 citations73
US12344677B2Jul 1, 2025

Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof

REGENERON PHARMA0 citations62
US12325752B2Jun 10, 2025

Immunoglobulin proteins that bind to NPR1 agonists

REGENERON PHARMA0 citations58
US10584173B2Mar 10, 2020

Nucleic acids encoding high affinity antibodies to human IL-6 receptor

REGENERON PHARMA0 citations52
US10787522B2Sep 29, 2020

VL antigen binding proteins exhibiting distinct binding characteristics

REGENERON PHARMA0 citations41

STEVENS SEAN

3 patents

RADIN ALLEN

3 patents